Autosomal dominant adult-onset proximal spinal muscular atrophy

Get in touch with RARE Concierge.

Contact RARE Concierge

Autosomal dominant adult-onset proximal spinal muscular atrophy

Synonyms: Autosomal dominant adult-onset proximal SMA | Autosomal dominant late-onset spinal muscular atrophy, Finkel type | Finkel disease | SMAFK

A rare genetic motor neuron disease characterized by adulthood-onset of slowly progressive proximal muscular weakness with fasciculations amyotrophy cramps and absent/hypoactive reflexes without bulbar or pyramidal involvement.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version March 2024

Newly diagnosed with
Autosomal dominant adult-onset proximal spinal muscular atrophy?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Cure SMA

Cure SMA leads the way to a world where everyone impacted by spinal muscular atrophy (SMA) is empowered to lead independent, successful, and fulfilling lives. We strive to create a community where every individual is heard and feels welcomed. Cure SMA provides practical support programs for our community and advocates for their needs. We fund and direct comprehensive research that drives breakthro

Friends of Be an Angel

To support Ukrainian refugees and rescue efforts. We provide humanitarian aid, medical evacuations and mental health education programs for the Ukrainian people suffering from the full-scale invasion. Join us to provide a future for those most vulnerable.

Genetic Support Network of Victoria

The Genetic Support Network of Victoria is an organisation that supports people living with genetic, undiagnosed and rare conditions and those who support them including community and families, patient support organisations, health professionals and industry. Our vision is our community flourishing and living their best lives.

Clinical Trials

For a list of clinical trials in this disease area, please click here.